Notice names this product. B BRAUN MEDICAL’s DEXTROSE INJECTION USP is named in FDA Class II recall D-0496-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. Identifying details: Lot # J5H166, J5H167, Exp Date: 30NOV2026.. Units affected: 17,124 bags. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Company / brand: B BRAUN MEDICAL recalls
Affected product: DEXTROSE INJECTION USP recall status
Official ID D-0496-2026 · Official record ↗
See all B BRAUN MEDICAL recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 6:00 PM UTC.